ORBIMED ADVISORS LLC – Eli Lilly and Company Transaction History
ORBIMED ADVISORS LLC portfolio value:
$4.85M
portfolio value
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | call | Increase | 0.00% | 15K shares | 4.85M | $323.35 | 15K |
| Q1 2018 | share | Decrease | -100.00% | -2.28M shares | -193.24M | $71.78 | 0 |
| Q4 2017 | share | Decrease | -25.59% | -787K shares | -69.79M | $77.79 | 2.28M |
| Q3 2017 | share | 0.00% | 0 shares | 9.96M | $78.29 | 3.07M | |
| Q2 2017 | share | Decrease | -7.66% | -255.2K shares | -27.03M | $74.85 | 3.07M |
| Q1 2017 | share | Increase | +21.58% | 591.2K shares | 78.65M | $76 | 3.33M |
| Q1 2017 | call | Decrease | -100.00% | -150K shares | -11.03M | $76 | 0 |
| Q4 2016 | call | Decrease | -40.00% | -100K shares | -9.03M | $66.02 | 150K |
| Q4 2016 | share | Increase | +34.23% | 698.5K shares | 37.68M | $66.02 | 2.73M |
| Q3 2016 | share | Increase | +38.17% | 563.7K shares | 47.47M | $71.57 | 2.04M |
| Q3 2016 | call | Increase | 0.00% | 250K shares | 20.06M | $71.57 | 250K |
| Q2 2016 | share | Decrease | -41.89% | -1.06M shares | -66.70M | $69.79 | 1.47M |
| Q1 2016 | share | Increase | +57.55% | 928.3K shares | 47.08M | $63.39 | 2.54M |